HUP9904075A3 - Composition, for the treatment of asthma,containing loratadine and a decongestant - Google Patents

Composition, for the treatment of asthma,containing loratadine and a decongestant

Info

Publication number
HUP9904075A3
HUP9904075A3 HU9904075A HUP9904075A HUP9904075A3 HU P9904075 A3 HUP9904075 A3 HU P9904075A3 HU 9904075 A HU9904075 A HU 9904075A HU P9904075 A HUP9904075 A HU P9904075A HU P9904075 A3 HUP9904075 A3 HU P9904075A3
Authority
HU
Hungary
Prior art keywords
decongestant
asthma
treatment
composition
containing loratadine
Prior art date
Application number
HU9904075A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HUP9904075A2 publication Critical patent/HUP9904075A2/hu
Publication of HUP9904075A3 publication Critical patent/HUP9904075A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9904075A 1996-10-31 1997-10-29 Composition, for the treatment of asthma,containing loratadine and a decongestant HUP9904075A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (2)

Publication Number Publication Date
HUP9904075A2 HUP9904075A2 (hu) 2000-05-28
HUP9904075A3 true HUP9904075A3 (en) 2002-02-28

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904075A HUP9904075A3 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma,containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (sk)
JP (1) JP2000505104A (sk)
KR (1) KR20000052922A (sk)
CN (1) CN1235545A (sk)
AR (1) AR008908A1 (sk)
AU (1) AU731756B2 (sk)
BR (1) BR9712705A (sk)
CA (1) CA2268546A1 (sk)
CO (1) CO4910128A1 (sk)
CZ (1) CZ150999A3 (sk)
HU (1) HUP9904075A3 (sk)
ID (1) ID23431A (sk)
IL (1) IL129662A0 (sk)
NO (1) NO992062D0 (sk)
NZ (1) NZ335078A (sk)
PE (1) PE11399A1 (sk)
PL (1) PL333056A1 (sk)
SK (1) SK54599A3 (sk)
TR (1) TR199901003T2 (sk)
WO (1) WO1998018470A1 (sk)
ZA (1) ZA979731B (sk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021556A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
CO5271713A1 (es) * 1998-09-10 2003-04-30 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045676A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Extended release oral dosage composition
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
WO2001078782A1 (en) * 2000-04-14 2001-10-25 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
PE20020055A1 (es) * 2000-05-25 2002-02-12 Schering Corp Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
CN1518448A (zh) * 2001-06-20 2004-08-04 ���鹫˾ 用于治疗鼻充血和鼻塞的抗组胺剂
CA2612179C (en) 2005-06-17 2016-08-02 Aft Pharmaceuticals Limited A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion
BRPI0712532A2 (pt) * 2006-06-01 2013-04-02 Schering Plough Healthcare Prod Inc formulaÇÕes e composiÇÕes farmacÊuticas de fenilefrina para absorÇço colânica
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
ZA979731B (en) 1998-04-29
NO992062L (no) 1999-04-29
JP2000505104A (ja) 2000-04-25
AR008908A1 (es) 2000-02-23
CN1235545A (zh) 1999-11-17
ID23431A (id) 2000-04-20
KR20000052922A (ko) 2000-08-25
SK54599A3 (en) 2000-08-14
TR199901003T2 (xx) 1999-07-21
BR9712705A (pt) 1999-10-26
CZ150999A3 (cs) 1999-10-13
CA2268546A1 (en) 1998-05-07
HUP9904075A2 (hu) 2000-05-28
WO1998018470A1 (en) 1998-05-07
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
AU4995397A (en) 1998-05-22
IL129662A0 (en) 2000-02-29
PE11399A1 (es) 1999-02-09
CO4910128A1 (es) 2000-04-24
NO992062D0 (no) 1999-04-29
PL333056A1 (en) 1999-11-08
EP0941091A1 (en) 1999-09-15

Similar Documents

Publication Publication Date Title
NZ294392A (en) Asthma drugs and compounds
AU133903S (en) Inhaler device
HRP960365B1 (en) New medicaments and the use thereof
GB9606805D0 (en) Medicaments
HUP9904075A3 (en) Composition, for the treatment of asthma,containing loratadine and a decongestant
NZ314384A (en) Dimethyl-(3-aryl-but-3-enyl)-amines and medicaments thereof
GB2322568B (en) Gas treatment devices
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
EP0890599A4 (en) POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF
IL140742A0 (en) Raloxifene and pharmaceutical composition comprising the same
GB9611947D0 (en) Medicaments
PL322596A1 (en) Antiglucocorticoid drug
ZA973843B (en) Treatment of asthma with TNFR-lg.
GB2294646B (en) Material treatment
GB2355006B (en) Materials treatment
GB9415901D0 (en) Novel compounds and treatment
GB9606721D0 (en) Infusion packages and methods for their manufacture
HUP0103569A3 (en) New medicament and process for its preparation
HUP0001725A3 (en) Process for the manufacture of corks and corks manufactured using this process
GB9415900D0 (en) Novel compounds and treatment
HUP0003908A2 (en) Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma
EP0699719A3 (de) Azofarbstoffe, Verfahren zu deren Herstellung und deren Verwendung
GB9727276D0 (en) Improvements in medicaments for asthma treatment
GB9825972D0 (en) Improvements in medicaments for asthma treatment
GB9615387D0 (en) Dispensing device and process